For citations:
Dzhanyan IA, Khagazheeva MN, Breder VV, Yudin DI, Pogrebnyakov IV, Kuzminov AE, Antonova EY, Starostin NM. Atezolizumab and bevacizumab in the treatment of advanced hepatocellular cancer with adverse factors and tumor thrombosis. Meditsinskiy sovet = Medical Council. 2023;(11):10-17. (In Russ.) https://doi.org/10.21518/ms2023-177